Oncotarget

Vol 9, No 86

November 2, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 86 of Oncotarget features Figure 6, "Schematic representation of the duality of TXNIP function as it pertains to peritoneal carcinomatosis/sarcomatosis," by Spaeth-Cook, et al.

Table of Contents

Editorial

Antigen-armed antibodies against B-cell malignancies

Antigen-armed antibodies against B-cell malignancies

https://doi.org/10.18632/oncotarget.26276

Marta Ilecka, Dwain G. van Zyl,  and Henri-Jacques Delecluse
35601-35602
PDF  |  Order a Reprint

B2M, JAK2 and MET in the genetic landscape of immunotolerance in lung cancer

B2M, JAK2 and MET in the genetic landscape of immunotolerance in lung cancer

https://doi.org/10.18632/oncotarget.26277

Montse Sanchez-Cespedes
35603-35604
PDF  |  Order a Reprint

Precision virotherapies: Coming soon

Precision virotherapies: Coming soon

https://doi.org/10.18632/oncotarget.26280

Hanni Uusi-Kerttula,  and Alan L. Parker
35605-35606
PDF  |  Order a Reprint

Should we measure clonal circulating plasma cells in light chain amyloidosis?

Should we measure clonal circulating plasma cells in light chain amyloidosis?

https://doi.org/10.18632/oncotarget.26289

Surbhi Sidana, Shaji K. Kumar,  and Wilson I. Gonsalves
35607-35608
PDF  |  Order a Reprint

Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations

Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations

https://doi.org/10.18632/oncotarget.26292

Hirokazu Okayama, Masaru Noda,  and Koji Kono
35609-35610
PDF  |  Order a Reprint

Research Papers

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

https://doi.org/10.18632/oncotarget.26242

Joshua N. Kellner, Eveline M. Delemarre, Eric Yvon, Stefan Nierkens, Jaap J. Boelens, Ian McNiece, Amanda Olson, Yago Nieto, Stefan Ciurea, Uday Popat, Sairah Ahmed, Richard Champlin, Jennifer Ramos, Mitsutaka Nishimoto, Hongbing Ma, Zeng Ke, Peter Thall, Joseph D. Khoury, Robert Negrin, Borje Andersson,  and Simrit Parmar
35611-35622
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer

https://doi.org/10.18632/oncotarget.26256

Elena Fountzilas, Vassiliki Kotoula, Ioannis Tikas, Kyriaki Manousou, Kyriaki Papadopoulou, Christos Poulios, Vasilios Karavasilis, Ioannis Efstratiou, Dimitrios Pectasides, Kleo Papaparaskeva, Ioannis Varthalitis, Christos Christodoulou, George Papatsibas, Sofia Chrisafi, Georgios K. Glantzounis, Amanda Psyrri, Gerasimos Aravantinos, Georgia-Angeliki Koliou, George K. Koukoulis, George E. Pentheroudakis,  and George Fountzilas
35623-35638
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells

DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells

https://doi.org/10.18632/oncotarget.26257

Isabel Castro-Piedras, Monica Sharma, Meghan den Bakker, Deborah Molehin, Edgar G. Martinez, David Vartak, Wendy M. Pruitt, Jena Deitrick, Sharilyn Almodovar,  and Kevin Pruitt
35639-35654
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas

Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas

https://doi.org/10.18632/oncotarget.26273

Michael D. Caponegro, Richard A. Moffitt,  and Stella E. Tsirka
35655-35665
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical associations of mucin 1 in human lung cancer and precancerous lesions

Clinical associations of mucin 1 in human lung cancer and precancerous lesions

https://doi.org/10.18632/oncotarget.26278

Andreas Saltos, Farah Khalil, Michelle Smith, Jiannong Li, Michael Schell, Scott J. Antonia,  and Jhanelle E. Gray
35666-35675
Abstract  |  PDF  |  HTML  |  Order a Reprint

Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition

Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition

https://doi.org/10.18632/oncotarget.26281

Douglas Spaeth-Cook, Mark Burch, Robin Belton, Bryce Demoret, Nicholas Grosenbacher, Jason David, Colin Stets, David Cohen, Reena Shakya, John L. Hays,  and James L. Chen
35676-35686
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

https://doi.org/10.18632/oncotarget.26286

Begoña Martin-Castillo, Sonia Pernas, Joan Dorca, Isabel Álvarez, Susana Martínez, Jose Manuel Pérez-Garcia, Norberto Batista-López, César A. Rodríguez-Sánchez, Kepa Amillano, Severina Domínguez, Maria Luque, Agostina Stradella, Idoia Morilla, Gemma Viñas, Javier Cortés, Elisabet Cuyàs, Sara Verdura, Álvaro Fernández-Ochoa, Salvador Fernández-Arroyo, Antonio Segura-Carretero, Jorge Joven, Elsa Pérez, Neus Bosch, Margarita Garcia, Eugeni López-Bonet, Samiha Saidani, Maria Buxó,  and Javier A. Menendez
35687-35704
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients

EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients

https://doi.org/10.18632/oncotarget.26298

Sanne de Wit, Mariangela Manicone, Elisabetta Rossi, Rita Lampignano, Liwen Yang, Beate Zill, Alvera Rengel-Puertas, Marianne Ouhlen, Mateus Crespo, Anne Margreet Sofie Berghuis, Kiki Carlijn Andree, Riccardo Vidotto, Elisabeth Katharina Trapp, Marie Tzschaschel, Emeline Colomba, Gemma Fowler, Penelope Flohr, Pasquale Rescigno, Mariane Sousa Fontes, Rita Zamarchi, Tanja Fehm, Hans Neubauer, Brigitte Rack, Marianna Alunni-Fabbroni, Françoise Farace, Johann De Bono, Maarten Joost IJzerman,  and Leonardus Wendelinus Mathias Marie Terstappen
35705-35716
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC